Micron Targets 85% Upside as UBS Resets Valuation

 TechStockTracker
 
  TechStockTracker
 
Follow  Message
 
 
TechStockTracker decode the complex world of finance and investments, with a special emphasis on the dynamic intersection of technology and dividend growth stocks.
 

•  10 Aug 2026
 

$MU Micron Technology received a $1,625 price target from UBS, implying roughly 85% upside from its current price near $880, as the Swiss bank reiterated its Buy rating. The stock is up about 0.3% and trades roughly 30% below its $1,255 high over the past year. UBS previously had a $535 price target, less than one third of its new target. The catalyst is a structural reset in the earnings capacity of the memory industry.

UBS argues that the memory market has shifted away from the sharp cyclicality in which investment waves create excess supply and erase profits within a year. Analysts instead describe longer supply agreements, prices locked in advance, and demand visibility extending well beyond the next quarter. That durability supports multiple expansion toward levels closer to the broader semiconductor sector. The new target is based on roughly 11 times projected 2029 earnings per share of about $165, discounted back one year.

An 11 times multiple means investors are paying $11 for each dollar of annual earnings, a relatively modest level compared with current semiconductor valuations. The larger factor in the valuation is therefore the scale of projected future earnings rather than multiple expansion itself. Revenue of about $41.5 billion in the latest quarter set a company record, while guidance for the next quarter stands at about $50 billion. Gross margin rose to about 85%, with management targeting roughly 86% in the coming quarter.

Adjusted earnings per share reached about $25, while operating cash flow totaled roughly $25 billion in a single quarter. The unit supplying memory to cloud providers contributed about $13.8 billion of revenue, while adjusted free cash flow reached approximately $18 billion. The company market capitalization is around $1 trillion, a threshold it crossed for the first time in recent months and one that placed it among the ten largest companies in the S&P 500. Its DRAM market share stands at about 22%, compared with roughly 38% for Samsung and 29% for SK Hynix.

The stock has a 52 week low of $113.46, leaving its current price more than seven times higher. Volatility of that magnitude helps explain some of the caution around long dated valuation multiples, because a market that priced such a rise within a year can react sharply to early signs of cooling memory prices. About 30% of industry DRAM wafer production is expected to be allocated to HBM by 2027, according to market estimates. That shift reduces capacity available for conventional memory and also pushes its prices higher.

Major manufacturers report that their production is almost fully sold for the coming year, while HBM contracts for the following year are being closed on terms that tend to favor suppliers. Micron supplies this component for artificial intelligence accelerators, allowing the company to benefit simultaneously from higher pricing and longer commitments that stabilize its outlook. HBM4 is already being shipped in volume to a major customer, while mass production of HBM4E is planned for 2027. These conditions reinforce earnings momentum and extend visibility into future demand.

Chinese producer CXMT remains on the other side of the equation. Its Shanghai listing and reports of production capacity expansion drove Micron shares down about 6% in a single trading day, even though its DRAM market share is estimated at about 8% and it remains several years behind in advanced HBM generations. US export restrictions on advanced lithography equipment make it more difficult for CXMT to close that gap quickly. The reaction shows how sensitive institutional flows remain to signs of future supply growth.

The gap between $880 and $1,625 reflects one central assumption: that current exceptional profitability can persist for close to a decade. At the current price, the stock trades at roughly five times the same 2029 earnings forecast, a valuation that reflects market skepticism about the duration of the current cycle. The next quarter, with revenue guidance of about $50 billion, is the nearest test of that assumption.

View all market intelligence